|
|||||
|
|
Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma |
|
| Authors: | Mary Lou Affronti Jennifer Gamboa Jackman Frances McSherry James E. Herndon II Elwood C. Massey Jr. Eric Lipp Annick Desjardins Henry S. Friedman Gordana Vlahovic James Vredenburgh Katherine B. Peters |
| Affiliation: | 1. Duke University Medical Center, Durham, North Carolina, USA;2. Duke University, Durham, North Carolina, USA;3. AstraZeneca, Gaithersburg, Maryland, USA;4. Saint Francis Hospital, Hartford, Connecticut, USA |
| Abstract: | |
| Keywords: | |